Myriad Genetics Inc (NAS:MYGN)
$ 26.835 0.445 (1.69%) Market Cap: 2.44 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 3.29 GF Score: 78/100

Myriad Genetics Inc Annual Shareholders Meeting Transcript

Jun 03, 2021 / 02:00PM GMT
Release Date Price: $27.24 (-3.34%)
S. Louise Phanstiel
Myriad Genetics, Inc. - Independent Chair of the Board

Welcome to the 2021 Annual Meeting of Stockholders of Myriad Genetics, Inc. I'm Louise Phanstiel, Chair of the Board of Directors, and it is my pleasure to welcome you. It is 8:00 a.m. Mountain Standard Time, and in accordance with the notice of the meeting, I call to order the 2021 Annual Meeting of Stockholders of Myriad Genetics.

On the website, there is an agenda for the meeting and rules of conduct. We will conduct this meeting in accordance with the agenda and those rules. There will be an opportunity for questions later in the webcast. Please adhere to the rules of conduct attached to your agenda in asking questions or making comments at that time.

Before proceeding to the business of the meeting, I'd like to introduce you to our Directors, including those who are up for election this year. Paul J. Diaz joined Myriad as a Director and our Chief Executive Officer in August 2020. Previously, Mr. Diaz served as a partner in the private equity firm of Cressey & Company, and prior to that, he had been the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot